(2019-12-11)
http://www.etnews.com/20191211000027
'VROR', a virtual reality (VR) eye tester, was approved by the US Food and Drug Administration (FDA).
M2S develops and operates eye-related care services and platforms such as VROR, an ophthalmologic tester using VR.
VR Ophthalmic Examiner 'VROR' has implemented various ophthalmic examinations such as visual inspection to check glaucoma in ophthalmology, pupil inspection to check pupil size and reaction rate, diplopia and strabismus examination as well as external ocular muscle.
Tae-Hwi, Lee, CEO of M2S, said, “The medical insurance system is well-established in Korea, so it is possible to provide sufficient medical services. However, it is not easy to receive even simple eye examination services overseas.”